Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study

MLA

Allan Gibofsky, et al. “Real-World Utilization of DMARDs and Biologics in Rheumatoid Arthritis: The RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) Study.” Current Medical Research and Opinion, vol. 22, Dec. 2005, pp. 169–83. EBSCOhost, https://doi.org/10.1185/030079906x80341.

APA

Allan Gibofsky, Arthur L. Weaver, Joseph A. Markenson, Harold E. Paulus, Michael Schiff, Jonathan A Leff, John A. Goldman, James B Whitmore, Richard L Lautzenheiser, Melanie J. Harrison, Edward C. Keystone, & William R Palmer. (2005). Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Current Medical Research and Opinion, 22, 169–183. https://doi.org/10.1185/030079906x80341

Chicago

Allan Gibofsky, Arthur L. Weaver, Joseph A. Markenson, Harold E. Paulus, Michael Schiff, Jonathan A Leff, John A. Goldman, et al. 2005. “Real-World Utilization of DMARDs and Biologics in Rheumatoid Arthritis: The RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) Study.” Current Medical Research and Opinion 22 (December): 169–83. doi:10.1185/030079906x80341.